Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition

Details for Australian Patent Application No. 2005237360 (hide)

Owner Astellas Pharma Inc.

Inventors Maeda, Atsushi; Yoshida, Takayuki; Tasaki, Hiroaki; Katsuma, Masataka

Agent Davies Collison Cave

Pub. Number AU-B-2005237360

PCT Pub. Number WO2005/105045

Priority US60/567,301 30.04.04 US

Filing date 28 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 21 October 2010

International Classifications

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

Event Publications

26 April 2007 Section 223 Application Allowed

  Astellas Pharma Inc. The time in which to enter the National Phase has been extended to 28 Feb 2007. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

10 May 2007 PCT application entered the National Phase

  PCT publication WO2005/105045 Priority application(s): WO2005/105045

21 October 2010 Application Accepted

  Published as AU-B-2005237360

17 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237364-Method for reducing gastrointestinal toxicity due to the administration of tegafur

2005237341-Oil or fat composition